Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.17495
+0.00495 (2.91%)
At close: Sep 17, 2026
Integrated BioPharma Market Cap
Integrated BioPharma has a market cap or net worth of $5.43 million as of September 17, 2026. Its market cap has decreased by -38.98% in one year.
Market Cap
5.43M
Enterprise Value
2.95M
Revenue
48.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
ChartMarket Cap Chart
Since December 22, 1995, Integrated BioPharma's market cap has decreased from 25.02M to 5.43M, a decrease of -78.28%. That is a compound annual growth rate of -4.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 5.43M | -50.72% |
| Dec 31, 2025 | 11.03M | 10.37% |
| Dec 27, 2024 | 9.99M | 35.38% |
| Dec 29, 2023 | 7.38M | -29.98% |
| Dec 30, 2022 | 10.54M | -66.03% |
| Dec 29, 2021 | 31.03M | 41.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eat Well Investment Group | 10.72M |
| Glucose Health | 10.69M |
| Next Meats Holdings | 10.50M |
| NutraProducts | 9.18M |
| Cellev8 Nutrition | 8.89M |
| Wenyuan Group | 7.50M |
| Strake | 6.16M |
| BAB, Inc. | 6.15M |